Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants

The veterinary medicinal product is to be used at the maximum recommended
dose of 3 mg/kg/day for 10 consecutive days for the treatment of Raillietina
echinobothrida
poultry.

Revised: March 2024
AN: 02426/2023Page 2 of 8
Do not use the veterinary medicinal product at this dose regimen in intensively
reared broiler chickens which are unlikely to be infected with Raillietina
echinobothrida
Unnecessary use of antiparasitics or use deviating from the instructions given in
the SPC may increase the resistance selection pressure and lead to reduced
efficacy. The decision to use the veterinary medicinal product should be based
on confirmation of the parasitic species and burden, or of the risk of infection
based on its epidemiological features, for each flock.
Repeated use for an extended period, particularly when using the same class of
substances, increases the risk of resistance development. Within a flock,
maintenance of susceptible refugia is essential to reduce that risk. Systematically
applied interval-based treatment and treatment of a whole flock should be
avoided. Instead, if feasible, only selected individual animals or subgroups should
be treated (targeted selective treatment). This should be combined with
appropriate husbandry and pasture management measures. Guidance for each
specific flock should be sought from the responsible veterinarian.
The use of this veterinary medicinal product should take into account local
information about susceptibility of the target parasites, where available.
It is recommended to further investigate cases of suspected resistance, using an
appropriate diagnostic method (e.g. Faecal Egg Count Reduction Test (FECRT).
Confirmed resistance should be reported to the marketing authorisation holder or
to the competent authorities.

i). Special precautions for use in animals
The safety of the veterinary medicinal product at overdose has not been
evaluated in chickens of less than 14 days of age and in pheasants of less than 3
weeks of age.
ii). Special precautions to be taken by the person administering the veterinary
medicinal product to animals
- Embryotoxic effects cannot be excluded. Pregnant women must take extra
precautions when handling this veterinary medicinal product.
- This veterinary medicinal product may be toxic to humans after ingestion.
- This veterinary medicinal product may cause eye irritation.
- Contact with the skin and the eyes or accidental ingestion of the veterinary
medicinal product should be avoided.
- Do not smoke, eat or drink when handling the veterinary medicinal product.

Revised: March 2024
AN: 02426/2023Page 3 of 8
- In the event of accidental ingestion, rinse mouth with plenty of clean water
and seek medical advice. In the event of accidental contact with the skin or
eyes, rinse with plenty of clean water and seek medical advice.
- Wash hands after use.
iii). Other precautions
The veterinary medicinal product should not enter water courses as
fenbendazole may be dangerous for fish and other aquatic organisms.